How to Trip Rapid Review

Step 1: Select articles relevant to your search (remember the system is only optimised for single intervention studies)

Step 2: press

Step 3: review the result, and maybe amend the or if you know better! If we're unsure of the overall sentiment of the trial we will display the conclusion under the article title. We then require you to tell us what the correct sentiment is.

1,960 results for

Cholesterol Education Resources

by
...
Latest & greatest
Alerts

Export results

Use check boxes to select individual results below

SmartSearch available

Trip's SmartSearch engine has discovered connected searches & results. Click to show

381. Treatment of Hypertension in Patients With Coronary Artery Disease

lipoprotein cholesterol) and an elevated fasting blood glucose level. 1.1.3. Risk Factor Reduction Hypertension, dyslipidemia, diabetes mellitus, cigarette smoking, obesity, and chronic kidney disease (CKD) are independent determinants of CVD risk. Moreover, a diagnosis of peripheral artery disease (PAD) significantly increases the risk for both prevalent and incident disease in other vascular beds including the coronary and cerebral circulations. , As indicated previously, hypertension represents (...) predisposition/family history are not addressed in this report. The potentially modifiable risk factors include dyslipidemia, diabetes mellitus, smoking, obesity, PAD, and renal insufficiency. 1.1.4. Dyslipidemia The management of dyslipidemia was the subject of a recent ACC/AHA guideline. In essence, the new guideline does not support continued use of specific low-density lipoprotein (LDL) cholesterol or non–high-density lipoprotein cholesterol treatment targets. The guideline advocates the use of a 10-year

Full Text available with Trip Pro

2015 American Heart Association

382. Workplace Wellness Recognition for Optimizing Workplace Health

of health and achievement of rigorous standards for cardiovascular health based on Life’s Simple 7 metrics. In addition, the American Heart Association/American Stroke Association will develop resources that assist employers in meeting these rigorous standards, facilitating access to high-quality comprehensive workplace wellness programs for both employees and dependents, and fostering innovation and additional research. Introduction There are an estimated 155 million working-age, largely employed (...) a contemporary survey found that ≈77% of employers, including all large employers, reported offering workplace wellness programs, definitions of wellness programs vary, and there is a lack of recent evidence of the prevalence of comprehensive programs. To be considered comprehensive, programs must have all 5 elements described by Healthy People 2010: health education, supportive social and physical environments, integration into other organizational initiatives, linkage to other related programs

2015 American Heart Association

383. Future Translational Applications From the Contemporary Genomics Era

educational and advisory programs at centers to bridge the chasm between discovery and development in commercialization of translatable technologies NCATS Oversees the CTSA program, making available critical resources required for the development of new therapies, promoting the notion of regulatory science to facilitate effective and efficient evaluation of novel diagnostics and therapeutics, and providing molecular libraries for therapeutic screens AHA Science & Technology Accelerator Program AHA program (...) are waiting to be used. Although new strategies exist, many academic laboratories may not be well versed in or even aware of these methodologies. Moreover, these techniques require time, experience, and education from investigators and laboratory staff. How this learning process can best be facilitated is unclear. The field of CVD has much to gain from these strategies, given that CVD is currently the leading cause of death in the United States. Thus, the purpose of this scientific statement is to detail

Full Text available with Trip Pro

2015 American Heart Association

384. Society for Vascular Surgery practice guidelines for atherosclerotic occlusive disease of the lower extremities: Management of asymptomatic disease and claudication

amount of resources in the United States health care system. Overall rates of intervention for PAD have been rising steadily in recent years. Changing demographics, evolution of technologies, and an expanding database of outcomes studies are primary forces influencing clinical decision making in PAD. The management of PAD is multidisciplinary, involving primary care physicians and vascular specialists with varying expertise in diagnostic and treatment modalities. PAD represents a broad spectrum (...) of C-reactive protein and the risk of future cardiovascular events among apparently healthy women. Circulation . 1998 ; 98 : 731–733 | | , x 24 Ridker, P., Stampfer, M.J., and Rifai, N. Novel risk factors for atherosclerosis: a comparison of C-reactive protein, fibrinogen, homocysteine, lipoprotein (a), and standard cholesterol screening as predictors of peripheral arterial disease. JAMA . 2001 ; 285 : 2481–2485 | | , x 25 Wilson, A.M., Shin, D.S., Weatherby, C., Harada, R.K., Ng, M.K., Nair, N. et

Full Text available with Trip Pro

2015 Society for Vascular Surgery

385. Basic Concepts and Potential Applications of Genetics and Genomics for Cardiovascular and Stroke Clinicians

the clinical use of genetics and genomics knowledge and those who are not. Thus, there is a critical need to foster genetics/genomics literacy among all involved in the care of cardiovascular and stroke patients because it can be expected that these topics will transform the way medicine is practiced. The purpose of this document is to serve as a resource for practitioners in cardiovascular and stroke medicine on the application of genetics and genomics to patient care. Although not exhaustive, it contains (...) an overview of the field written specifically to be accessible and relevant to practitioners. It also refers to additional educational materials available in the literature, in textbooks, and on the Internet. (Because this article is intended to be primarily educational in nature, rather than providing a review of the literature, citations are limited to a small number of research articles and reviews of exceptional interest.) It recommends a core knowledge base with which practitioners and especially

Full Text available with Trip Pro

2015 American Heart Association

386. 2015 ACC/AHA Focused Update of Secondary Prevention Lipid Performance Measures

) based on the new recommendations in the “2013 ACC/AHA Guideline on the Treatment of Blood Cholesterol to Reduce Atherosclerotic Cardiovascular Risk in Adults” (the Cholesterol Guideline). In this measure set, the writing committee presents 5 PMs ( ) 3 of which are intended for ambulatory settings and 2 for hospital (inpatient) settings. Four are revisions of lipid management measures appearing in 4 existing measure sets: “ACCF/AHA/ACR/SCAI/SIR/SVM/SVN/SVS 2010 Performance Measures for Adults (...) Percentage of patients with STEMI/NSTEMI who are ≥18 y of age with documented LDL-C level in the hospital record or documented LDL-C testing done during the hospital stay or planned for after discharge ACC/AHA indicates American College of Cardiology/American Heart Association; CAD, coronary artery disease; LDL-C, low-density lipoprotein cholesterol; NSTEMI, non–ST-elevation myocardial infarction; PAD, peripheral artery disease; PCI, percutaneous coronary intervention; PM, performance measure; and STEMI

2015 American Heart Association

387. Eligibility and Disqualification Recommendations for Competitive Athletes with Cardiovascular Abnormalities: Task Force 8: Coronary Artery Disease

Originally published November 2, 2015 Keywords Subjects Title Title Title Title Circulation AHA Journals Journal Information Subjects Features Resources & Education For Authors & Reviewers National Center 7373 Greenville Ave. Dallas, TX 75231 Customer Service 1-800-AHA-USA-1 1-800-242-8721 ABOUT US OUR SITES TAKE ACTION ONLINE COMMUNITIES Follow Us: © American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. The American Heart Association is qualified 501(c)(3) tax-exempt (...) a prospective assessment of effect and time course. JACC Cardiovasc Imaging . 2011 ; 4 :977–986. doi: 10.1016/j.jcmg.2011.06.013. Stone NJ, Robinson JG, Lichtenstein AH, Bairey Merz CN, Blum CB, Eckel RH, Goldberg AC, Gordon D, Levy D, Lloyd-Jones DM, McBride P, Schwartz JS, Shero ST, Smith SC, Watson K, Wilson PW . 2013 ACC/AHA guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular risk in adults: a report of the American College of Cardiology/American Heart Association

2015 American Heart Association

388. Sex Differences in the Cardiovascular Consequences of Diabetes Mellitus

in women undergoing revascularization and increased postsurgical mortality are seen in women but not men with DM CHD indicates coronary heart disease; CVD, cardiovascular disease; DM, diabetes mellitus; HbA 1c , hemoglobin A 1c ; HDL-C, high-density lipoprotein cholesterol; PAD, peripheral arterial disease; and T1DM, type 1 diabetes mellitus. Table 2. Sex Differences in CVD Treatments and Interventions in DM CVD Treatment/Intervention Sex Differences Prescription of pharmacotherapy Compared with men (...) , women have lower frequency of lipid-lowering (statin) therapy, lower aspirin use, and lower ACE inhibitor and β-blocker use Lower medication adherence in women compared with men in some but not all studies Statin therapy Equally effective for secondary CVD prevention in both men and women No prospective evidence for primary CVD with statins in women; however, on the basis of expert opinion and cholesterol theory of atheroma progression, statins are recommended for primary prevention in women

Full Text available with Trip Pro

2015 American Heart Association

389. Medical eligibility criteria for contraceptive use

States of America [USA]), Jacqueline Conard (Hôpital Universitaire de Paris – Hôtel Dieu, France), Maria del Carmen Cravioto (National Institute of Nutrition Salvador Zubiran, Mexico), Marc Dhont (Ghent University Hospital, Belgium), Alison Edelman (Oregon Health Sciences University, USA), Faysel El-Kak (American University of Beirut, Lebanon), Mohammed Eslami (Ministry of Health and Education, Islamic Republic of Iran), Karima Gholbzouri (Ministry of Health, Morocco), Gathari Gichuhi (Jhpiego, Kenya (...) Fund (UNFPA) – Sennen Hounton • United States Food and Drug Administration (FDA) – Lisa Soule • United States National Institutes of Health (NIH) – Alicia Armstrong, Trent MacKay • USAID – Patricia MacDonald, James Shelton External Peer Review Group Anna Altshuler (Stanford University, USA), Parnian Andalib (Ministry of Education, Islamic Republic of Iran), Paul Blumenthal (Stanford University, USA), Vivian Brache (Profamilia, Dominican Republic), Caroline Phiri Chibawe (Ministry of Health, Zambia

2015 World Health Organisation Guidelines

390. Cardiac Screening With Electrocardiography, Stress Echocardiography, or Myocardial Perfusion Imaging: Advice for High-Value Care From the American College of Physicians

, and Society for Cardiovascular Magnetic Resonance endorsed by the Heart Rhythm Society and the Society of Critical Care Medicine. J Am Coll Cardiol 2008 51 1127 47 National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III (...) cardiovascular risk factors (total cholesterol level >5.2 mmol/L [>200 mg/dL], high-density lipoprotein cholesterol level <1.3 mmol/L [<50 mg/dL], smoker, and hypertensive or normotensive while receiving treatment), women younger than 60 years with 1 or 2 risk factors, and men younger than 55 years with no risk factors ( ). For example, a 60-year-old woman with average lipid levels (total cholesterol level of 5.5 mmol/L [211 mg/dL] and high-density lipoprotein cholesterol level of 1.5 mmol/L [59 mg/dL

2015 American College of Physicians

391. Guidelines for the management of spontaneous intracerebral hemorrhage

that prehospital CT scanning with an appropriately equipped ambulance is feasible and may allow for triage to an appropriate hospital and initiation of ICH-specific therapy. , ED Management Every ED should be prepared to treat patients with ICH or have a plan for rapid transfer to a tertiary care center. The crucial resources necessary to manage patients with ICH include neurology, neuroradiology, neurosurgery, and critical care facilities that include adequately trained nurses and physicians. Consultants

Full Text available with Trip Pro

2015 American Academy of Neurology

392. Guidelines for the Management of Spontaneous Intracerebral Hemorrhage

Words: AHA Scientific Statements ? blood pressure ? coagulopathy ? diagnosis ? intracerebral hemorrhage ? intraventricular hemorrhage ? surgery ? treatment Guidelines for the Management of Spontaneous Intracerebral Hemorrhage A Guideline for Healthcare Professionals From the American Heart Association/American Stroke Association The American Academy of Neurology affirms the value of this guideline as an educational tool for neurologists. Endorsed by the American Association of Neurological Surgeons (...) demonstrated to significantly shorten time to computed tomography (CT) scanning in the ED. 11 Two studies have shown that prehospital CT scanning with an appropri- ately equipped ambulance is feasible and may allow for tri- age to an appropriate hospital and initiation of ICH-specific therapy. 12,13 ED Management Every ED should be prepared to treat patients with ICH or have a plan for rapid transfer to a tertiary care center. The crucial resources necessary to manage patients with ICH include neurology

2015 Congress of Neurological Surgeons

393. Vasectomy

Vasectomy Vasectomy Guideline - American Urological Association advertisement Toggle navigation About Us About the AUA Membership AUA Governance Industry Relations Education AUAUniversity Education Products & Resources Normal Histology and Important Histo-anatomic Structures Urinary Bladder Prostate Kidney Renovascular Diseases Andrenal Gland Testis Paratesticular Tumors Penis Retroperitoneum Cytology Online Learning For Medical Students Exams/LLL/Certifications Exam Prep Research Research (...) Funding AUA Funding Research Education & Events Online Research Education Courses Research Resources Biorepositories and Other Resources Research Publications Research Career Opportunities Advocacy Scholar & Fellowship Programs Comment Letters & Resources International International Opportunities Annual Meeting Membership Collaborations Academic Exchanges Giving Back Practice Resources Coding and Reimbursement Practice Managers' Network (PMN) Patient Safety and Quality of Care Accreditations

2015 American Urological Association

394. Secondary Prevention After Coronary Artery Bypass Graft Surgery

are, whenever possible, evidence based. Writing group members performed these relevant supplemental literature searches with key search phrases, including but not limited to coronary artery bypass graft surgery; tobacco, smoking, and smoking cessation; blood pressure control and hypertension; cholesterol, hypercholesterolemia, lipids, lipoproteins, and dyslipidemia; physical activity, exercise, and exercise training; weight management, overweight, and obesity; type 2 diabetes mellitus management (...) -term antithrombotic therapy (such as AF, venous thromboembolism, or a mechanical prosthetic valve) ( Class III; Level of Evidence A ). Antithrombotic alternatives to warfarin (dabigatran, apixaban, rivaroxaban) should not be routinely administered early after CABG until additional safety data have accrued ( Class III; Level of Evidence C ). Lipid Management Statins and Low-Density Lipoprotein Management Elevated low-density lipoprotein (LDL) cholesterol levels strongly influence the process

Full Text available with Trip Pro

2015 American Heart Association

395. Clinical Practice Guideline on management of patients with diabetes and chronic kidney disease stage 3b or higher (eGFR <45 mL/min)

, well-balanced education on the different modalities, for example the Yorkshire Dialysis Decision Aid (YODDA) ( see link on website ) are essential first steps. In patients opting to start HD , we suggest prefering high flux over low flux when this is available (2C) . We suggest diabetes has no influence on the choice between HD or HDF (2B). In patients opting for HD, it is suggested that high-flux dialysis is preferred when this is available and affordable, consistent with the ERBP recommendation

Full Text available with Trip Pro

2015 European Renal Best Practice

396. ACS/ASCO Breast Cancer Survivorship Care Guideline

in usual breast cancer survivorship care and support (LOE = 0). Additional resources More information, including a data supplement with additional evidence Tables, is available with the online version of this article at and ; patient information is available at ; journal-based continuing education is available at Abbreviations: ACS, American Cancer Society; ASCO, American Society of Clinical Oncology; DEXA, dual-energy x-ray absorptiometry; GnRH, gonadotropin-releasing hormone; LOE, level of evidence (...) of these patients will eventually be discharged back to their primary clinician for ongoing follow-up. It should be noted that these patients remain at risk indefinitely for complications of their previous cancer treatment. Most also remain at risk indefinitely for local and/or systemic recurrence of their breast cancer. Gaps in post-treatment cancer survivorship resources and clinical follow-up care were identified through the work of the National Cancer Survivorship Resource Center (The Survivorship Center

2015 American Society of Clinical Oncology Guidelines

397. Menopausal Symptoms: Comparative Effectiveness of Therapies

decisionmakers—patients and clinicians, health system leaders, and policymakers, among others—make well-informed decisions and thereby improve the quality of health care services. This report is not intended to be a substitute for the application of clinical judgment. Anyone who makes decisions concerning the provision of clinical care should consider this report in the same way as any medical reference and in conjunction with all other pertinent information, i.e., in the context of available resources (...) of interest identified. The list of Technical Experts who participated in developing this report follows: Nananda Col, M.D., M.P.P., M.P.H., FACP President Shared Decision Making Resources Georgetown, ME Carolyn Crandall, M.D., M.S. Professor of Medicine, Division of General Internal Medicine and Health Services Research David Geffen School of Medicine at UCLA Los Angeles, CA Cynthia Pearson, B.A. Executive Director National Women’s Health Network Washington, DC Peer Reviewers Prior to publication

2015 Effective Health Care Program (AHRQ)

398. Health Disparities in Quality Indicators of Healthcare Among Adults with Mental Illness

questions or comments about this Brief, please . The Center for Information Dissemination and Education Resources (CIDER) is a VA HSR&D Resource Center charged with disseminating important HSR&D findings and information to policy makers, managers, clinicians, and researchers working to improve the health and care of Veterans. - This report is a product of VA/HSR&D's Quality Enhancement Research Initiative's (QUERI) Evidence-Based Synthesis Program (ESP), which was established to provide timely (...) was statistically significant. For low-density lipoprotein cholesterol (LDL-C) control, VA studies demonstrated no significant differences between VA users with and without SMI. However, the one study that provided comparative estimates outside the VA reported significant and negative effects of SMI on achieving adequate LDL-C control. This review found weak signals to suggest disparities in care for those with mental health diagnosis; however, results were generally inconsistent. Moreover, beyond diabetes care

2015 Veterans Affairs - R&D

399. Personalised Care Planning For Adults With Chronic Or Long-Term Health Conditions

is, how it should be delivered and by whom, as well as its cost-effectiveness. Studies need to have longer term follow up and comparable intervention protocols. The impact on multiple co-morbidities has not been evaluated nor the effect of its implementation on patients of different socio-economic and educational backgrounds. So, in Utopia…. ….where time, money, manpower and resources are plentiful, it is likely that personalised care plans would improve the management of chronic illness. Undoubtedly (...) with interest the implications of this , published in March 2015, looking at personalised care planning for adults with chronic or long-term health conditions. Common sense and experience might well lead us to expect that only good can come from involving patients more closely in their own care. But can this be demonstrated to be the case? And if so, how might it be incorporated into a service already struggling to cope with ever-increasing demands on time and resources? What is personalised care planning

2015 Evidently Cochrane

To help you find the content you need quickly, you can filter your results via the categories on the right-hand side >>>>